RDY logo

RDY Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$85.22 M
+$14.83 M+21.07%

March 31, 2024


Summary


Performance

RDY Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$143.25 M
+$7.92 M+5.85%

December 31, 2024


Summary


Performance

RDY Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDYbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

RDY Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.1%+62.9%
3 y3 years-57.8%-26.9%
5 y5 years+165.6%-26.9%

RDY Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-57.8%+21.1%-51.5%+143.3%
5 y5-year-57.8%+213.1%-51.5%+426.3%
alltimeall time-79.7%+725.5%-65.8%+485.3%

Dr Reddys Laboratories Limited Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$143.25 M(+5.8%)
Sep 2024
-
$135.34 M(+129.9%)
Jun 2024
-
$58.87 M(-30.9%)
Mar 2024
$85.22 M(+21.1%)
$85.22 M(-3.1%)
Dec 2023
-
$87.95 M(-45.4%)
Sep 2023
-
$160.93 M(+119.5%)
Jun 2023
-
$73.31 M(+4.2%)
Mar 2023
$70.39 M(-64.1%)
$70.39 M(-6.9%)
Dec 2022
-
$75.63 M(-32.3%)
Sep 2022
-
$111.64 M(+46.4%)
Jun 2022
-
$76.27 M(-61.1%)
Mar 2022
$195.87 M(-3.0%)
$195.87 M(-33.7%)
Dec 2021
-
$295.25 M(+119.9%)
Sep 2021
-
$134.28 M(+22.1%)
Jun 2021
-
$109.95 M(-45.5%)
Mar 2021
$201.90 M(+641.7%)
$201.90 M(+243.2%)
Dec 2020
-
$58.83 M(+12.1%)
Sep 2020
-
$52.49 M(-9.6%)
Jun 2020
-
$58.09 M(+113.4%)
Mar 2020
$27.22 M(-15.2%)
$27.22 M(-13.2%)
Dec 2019
-
$31.36 M(-26.6%)
Sep 2019
-
$42.71 M(+43.3%)
Jun 2019
-
$29.81 M(-7.1%)
Mar 2019
$32.08 M(-20.8%)
$32.08 M(+31.1%)
Dec 2018
-
$24.48 M(-53.0%)
Sep 2018
-
$52.12 M(+63.7%)
Jun 2018
-
$31.85 M(-21.4%)
Mar 2018
$40.52 M(-32.0%)
$40.52 M(+28.7%)
Dec 2017
-
$31.48 M(-16.4%)
Sep 2017
-
$37.64 M(-13.7%)
Jun 2017
-
$43.59 M(-26.9%)
Mar 2017
$59.61 M(-19.6%)
$59.61 M(-32.8%)
Dec 2016
-
$88.78 M(+142.9%)
Sep 2016
-
$36.55 M(-61.1%)
Jun 2016
-
$93.93 M(+26.7%)
Mar 2016
$74.11 M(-14.1%)
$74.11 M(-16.5%)
Dec 2015
-
$88.78 M(-12.4%)
Sep 2015
-
$101.35 M(+2.6%)
Jun 2015
-
$98.78 M(+14.5%)
Mar 2015
$86.25 M(-38.9%)
$86.25 M(-12.9%)
Dec 2014
-
$99.00 M(-25.8%)
Sep 2014
-
$133.43 M(+23.1%)
Jun 2014
-
$108.39 M(-23.2%)
Mar 2014
$141.22 M(+49.6%)
$141.22 M(-58.9%)
Dec 2013
-
$343.58 M(+87.7%)
Sep 2013
-
$183.07 M(+21.4%)
Jun 2013
-
$150.77 M(+59.7%)
Mar 2013
$94.40 M
$94.40 M(-41.1%)
DateAnnualQuarterly
Dec 2012
-
$160.36 M(+21.8%)
Sep 2012
-
$131.62 M(-11.7%)
Jun 2012
-
$149.00 M(+3.7%)
Mar 2012
$143.67 M(+12.0%)
$143.67 M(-54.1%)
Dec 2011
-
$312.66 M(+101.3%)
Sep 2011
-
$155.34 M(+27.3%)
Jun 2011
-
$121.99 M(-4.9%)
Mar 2011
$128.33 M(-12.6%)
$128.33 M(+39.5%)
Dec 2010
-
$92.01 M(-33.6%)
Sep 2010
-
$138.48 M(+1.1%)
Jun 2010
-
$137.00 M(-6.7%)
Mar 2010
$146.76 M(+32.9%)
$146.76 M(+23.0%)
Dec 2009
-
$119.31 M(-7.2%)
Sep 2009
-
$128.51 M(-0.8%)
Jun 2009
-
$129.49 M(+17.3%)
Mar 2009
$110.41 M(-40.3%)
$110.41 M(+40.3%)
Dec 2008
-
$78.67 M(-28.6%)
Sep 2008
-
$110.14 M(+27.4%)
Jun 2008
-
$86.47 M(-53.3%)
Mar 2008
$185.01 M(-55.8%)
$185.01 M(+16.2%)
Dec 2007
-
$159.26 M(-25.2%)
Sep 2007
-
$212.99 M(-22.3%)
Jun 2007
-
$274.19 M(-34.5%)
Mar 2007
$418.74 M(+400.9%)
$418.74 M(+10.8%)
Dec 2006
-
$377.89 M(+255.5%)
Sep 2006
-
$106.29 M(+41.4%)
Jun 2006
-
$75.17 M(-10.1%)
Mar 2006
$83.59 M(-60.8%)
$83.59 M(-53.8%)
Dec 2005
-
$180.99 M(-24.7%)
Sep 2005
-
$240.51 M(+0.9%)
Jun 2005
-
$238.47 M(+12.0%)
Mar 2005
$212.98 M(+110.4%)
$212.98 M(+61.7%)
Dec 2004
-
$131.74 M(+9.0%)
Sep 2004
-
$120.83 M(+34.1%)
Jun 2004
-
$90.07 M(-11.0%)
Mar 2004
$101.21 M(-32.5%)
$101.21 M(-20.3%)
Dec 2003
-
$126.97 M(-23.8%)
Sep 2003
-
$166.55 M(+0.8%)
Jun 2003
-
$165.25 M(+10.2%)
Mar 2003
$149.96 M(+43.2%)
$149.96 M(+4.3%)
Dec 2002
-
$143.74 M(+7.0%)
Sep 2002
-
$134.28 M(+3.8%)
Jun 2002
-
$129.32 M(+23.5%)
Mar 2002
$104.70 M(+914.2%)
$104.70 M(+26.0%)
Dec 2001
-
$83.08 M(+29.6%)
Sep 2001
-
$64.11 M(-4.5%)
Jun 2001
-
$67.15 M
Mar 2001
$10.32 M
-

FAQ

  • What is Dr Reddys Laboratories Limited annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?
  • What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents year-on-year change?

What is Dr Reddys Laboratories Limited annual cash & cash equivalents?

The current annual cash & cash equivalents of RDY is $85.22 M

What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high annual cash & cash equivalents is $418.74 M

What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?

Over the past year, RDY annual cash & cash equivalents has changed by +$14.83 M (+21.07%)

What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of RDY is $143.25 M

What is the all time high quarterly cash and cash equivalents for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high quarterly cash and cash equivalents is $418.74 M

What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents year-on-year change?

Over the past year, RDY quarterly cash and cash equivalents has changed by +$55.30 M (+62.88%)